Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Galectin Therapeutics Inc (GALT)
NASDAQ:GALT
RESEARCH TOOLSreports
Galectin Therapeutics (GALT) Ownership - Who Owns Galectin Therapeutics?
551 Followers
Galectin Therapeutics (GALT) Ownership Overview
44.17% Insiders
3.88% Mutual Funds
5.77% Other Institutional Investors
46.19% Public Companies and
Individual Investors
The ownership structure of Galectin Therapeutics (GALT) stock is a mix of institutional, retail and individual investors. Approximately 9.64% of the company’s stock is owned by Institutional Investors, 44.17% is owned by Insiders and 46.19% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 20, 2024 | Kevin D. Freeman Director | Bought | $5925 |
| Apr 30, 2024 | Richard A. Jr. Zordani Director | Bought | $3520 |
| Apr 25, 2024 | James Czirr >10% Owner | Sold | $76500 |
| Apr 25, 2024 | Joel Lewis President & Ceo,director | Bought | $3390 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,922,207 | Insider | 9.53% | 12,732,745 | |
| 2,978,275 | Insider | 4.79% | 6,403,291 | |
| 1,917,722 | Institution | 3.09% | 4,123,102 | |
| 1,896,621 | Institution | 3.05% | 4,077,735 | |
| 573,144 | Institution | 0.92% | 1,232,260 | |
| 415,999 | Institution | 0.67% | 894,398 | |
| 121,532 | Insider | 0.20% | 261,294 | |
| 109,445 | Insider | 0.18% | 235,307 | |
| 107,333 | Insider | 0.17% | 230,766 | |
| 107,189 | Insider | 0.17% | 230,456 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,896,621 | Institution | 3.05% | 4,077,735 | |
| 415,999 | Institution | 0.67% | 894,398 | |
| 37,318 | Institution | 0.06% | 80,234 | |
| 26,902 | Institution | 0.04% | 57,839 | |
| 17,413 | Institution | 0.03% | 37,438 | |
| 5,556 | Institution | <0.01% | 11,945 | |
| 4,853 | Institution | <0.01% | 10,434 | |
| 3,817 | Institution | <0.01% | 8,207 | |
| 1,506 | Institution | <0.01% | 3,238 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,247,562 | Institution | 2.01% | 3,393,369 | |
| 670,160 | Institution | 1.08% | 1,822,835 | |
| 348,641 | Institution | 0.56% | 749,578 | |
| 106,336 | Institution | 0.17% | 228,622 | |
| 75,525 | Institution | 0.12% | 205,428 | |
| 73,184 | Institution | 0.12% | 157,346 | |
| 53,742 | Institution | 0.09% | 122,532 | |
| 44,983 | Institution | 0.07% | 96,713 | |
| 9,851 | Institution | 0.02% | 22,460 | |
| 728 | Institution | <0.01% | 1,565 |
FAQ
Who Owns Galectin Therapeutics Inc (GALT)?
According to the latest TipRanks data, approximately 5.77% of the company's stock is held by institutional investors, 44.17% is held by insiders, and 46.19% is held by retail investors.
What percentage of Galectin Therapeutics Inc (GALT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 5.77% of Galectin Therapeutics Inc (GALT) stock is held by institutional investors.
What percentage of Galectin Therapeutics Inc (GALT) stock is held by retail investors?
According to the latest TipRanks data, approximately 46.19% of Galectin Therapeutics Inc (GALT) stock is held by retail investors.
Who owns the most shares of Galectin Therapeutics Inc (GALT)?
James Czirr owns the most shares of Galectin Therapeutics Inc (GALT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.